Common Misreadings of Peptide Purity Reports

What a purity figure actually is#

Most peptide purity values come from reversed-phase high-performance liquid chromatography (HPLC) with ultraviolet (UV) detection. The sample is separated into peaks, each peak's area is integrated, and the main peak's area is expressed as a percentage of the total. That is area percent: a relative measure, tied to one method. ICH Q6B, written for biotechnological products rather than synthetic peptides, puts the general point plainly: absolute purity is difficult to determine, results are method-dependent, and purity is usually estimated by a combination of methods.^[3]

If the basics are new, start with understanding peptide purity. The misreadings below assume that background.

Misreadings about what the number means#

1. "98% purity means the vial is 98% peptide by weight"#

Area percent describes the share of UV-absorbing signal in the main peak, not the share of mass in the vial. Material that produces little or no UV signal under the method's conditions, such as counter-ions, water and inorganic salts, does not appear in the calculation at all. A sample can show a high area percent while a meaningful fraction of its weight is something other than the target peptide. Content by weight is a separate measurement, covered under misreadings 8 and 9 below.

2. "One purity number covers every impurity"#

A single percentage hides the profile behind it. Synthetic peptides can carry several classes of related impurities, including deletion and insertion sequences, diastereomers from racemization, oxidized forms and deamidated forms.^[6] A total of 2% could be one impurity or twenty small ones, and they are not interchangeable. Regulators look at impurities individually for this reason: FDA's 2021 guidance on synthetic peptide ANDAs asks applicants to identify each peptide-related impurity at 0.10% of the drug substance or greater, and limits any new specified impurity to no more than 0.5%.^[4]

3. "The mass matched, so the sample is pure"#

A mass spectrometry (MS) result that matches the expected molecular weight shows that the target peptide is present. It says little about how much else is there, and some impurities, such as diastereomers, have exactly the same mass as the target. Identity and purity are separate questions answered by different measurements; see how to read a certificate of analysis for how the two sit side by side on a report.

Misreadings about method#

4. "The method and wavelength don't matter"#

Area percent depends on what the detector can see and what the column can separate. Different compounds absorb differently at a given UV wavelength, so changing the wavelength changes the relative peak areas. A gradient that lets an impurity co-elute with the main peak will report a higher purity than one that resolves it. ICH Q2(R2) frames validation as demonstrating that a procedure is fit for its intended purpose, and for separation methods it points to showing resolution of the two components that elute closest to each other.^[2] It also suggests confirming specificity with a second procedure based on a different measurement principle.^[2] FDA's peptide guidance likewise encourages orthogonal methods and sensitive, high-resolution procedures such as UHPLC-HRMS.^[4]

5. "Integration is automatic, so the percentage is objective"#

Peak areas depend on integration choices: where the baseline is drawn, how shoulders and partly overlapping peaks are split, and what minimum peak size is counted. Each is a legitimate parameter, and each can move a small percentage. USP <621> defines the chromatographic quantities these choices rest on, including resolution, signal-to-noise ratio and peak symmetry, and the harmonized chapter adds a general symmetry requirement of 0.8 to 1.8.^[1] A report that states its integration parameters and system suitability results is easier to evaluate than one that does not.

Misreadings about documentation#

6. "A stated '99%' is enough"#

A number without the chromatogram behind it cannot be checked. The trace shows whether the main peak is sharp and well separated, whether there are shoulders, and how impurities are distributed. This is not a hypothetical concern: in a study of 98 synthetic research peptides ordered at a minimum of 95.0% purity, all came with supplier certificates claiming at least that figure, yet fewer than half met it in the authors' own testing.^[5] In one sample the main compound had a different structure from the intended peptide.^[5]

7. "Any COA for this peptide applies to my sample"#

A certificate of analysis describes one batch. A document for a different lot, or one that does not carry a lot number at all, cannot speak for the material in hand. Matching the lot number on the vial, the certificate and any associated records is the basic check. The test date and the laboratory that performed the analysis are also worth noting, since they show which results the document actually reports.

Misreadings about composition#

8. "Counter-ions and water don't count"#

Peptides made by solid-phase synthesis are usually isolated as salts. Counter-ions such as trifluoroacetate can originate from the synthesis itself and remain in the final material, and residual solvents including water are among the attributes a full peptide specification addresses.^[6] Both add weight without adding peptide. Because they do not show in a UV area-percent result, a report that gives only HPLC purity is silent on them.

9. "Area percent and assay are the same thing"#

Area percent compares peaks within one chromatogram. An assay quantifies the amount of peptide against an external reference, typically a characterized reference standard of known content, and reports it as an amount or as a percentage by weight. ICH Q6B notes, for biotechnological products, that quantity is usually measured as protein content and is listed as a separate attribute from purity.^[3] The two answer different questions, and a report should label which one it gives.

Quick reference#

Reading a report with these in mind#

A useful purity report states its method and detection wavelength, shows the chromatogram, lists individual impurities above a stated reporting level, pairs the purity value with an identity result, and carries a lot number that matches the material. Where content by weight matters to an experiment, it also gives an assay or peptide content figure, or states that one was not determined. The authors of the research-peptide study above recommended that laboratories run their own quality checks, including MS, rather than rely on supplier certificates alone.^[5]

Renuvia Labs publishes each batch's COA in the COA library when testing is complete.